KalVista Pharmaceuticals Other Current Assets

KalVista Pharmaceuticals (KALV) currently reports a other current assets of $5.2M as of January 2026. That compares with $14M in the prior-year period — down 63.2% year over year. Use the charts on this page to explore KalVista Pharmaceuticals's other current assets history and peer comparisons.

KalVista Pharmaceuticals's other current assets decreased from $14M to $5.2M — a 63.2% year-over-year decrease (period ending January 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

KalVista Pharmaceuticals reported $5.2M in other current assets as of January 2026. That compares with $14M in the prior-year period — down 63.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $5.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for KalVista Pharmaceuticals, and consider following KALV for alerts when major investors trade the stock.

KalVista Pharmaceuticals is classified in the Healthcare sector. On other current assets, it currently shows $5.2M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KALV with unrelated industries.